Suppr超能文献

医学和牙科学中大麻的批判性评价:回顾与展望。

A critical review of cannabis in medicine and dentistry: A look back and the path forward.

机构信息

College of Dentistry, Department of Bioscience Research, The University of Tennessee Health Science Center, Memphis, Tennessee, USA.

College of Dentistry, Department of General Dentistry, The University of Tennessee Health Science Center, Memphis, Tennessee, USA.

出版信息

Clin Exp Dent Res. 2022 Jun;8(3):613-631. doi: 10.1002/cre2.564. Epub 2022 Apr 1.

Abstract

INTRODUCTION

In the last two decades, our understanding of the therapeutic utility and medicinal properties of cannabis has greatly changed. This change has been accompanied by widespread cannabis use in various communities and different age groups, especially within the United States. With this increase, we should consider the potential effects of cannabis-hemp on general public health and how they could alter therapeutic outcomes.

MATERIAL AND METHODS

The present investigation examined cannabis use for recreational and therapeutic use and a review of pertinent indexed literature was performed. The focused question evaluates "how cannabis or hemp products impact health parameters and do they provide potential therapeutic value in dentistry, and how do they interact with conventional medicines (drugs)." Indexed databases (PubMed/Medline, EMBASE) were searched without any time restrictions but language was restricted to English.

RESULTS

The review highlights dental concerns of cannabis usage, the need to understand the endocannabinoid system (ECS), cannabinoid receptor system, its endogenous ligands, pharmacology, metabolism, current oral health, and medical dilemma to ascertain the detrimental or beneficial effects of using cannabis-hemp products. The pharmacological effects of pure cannabidiol (CBD) have been studied extensively while cannabis extracts can vary significantly and lack empirical studies. Several metabolic pathways are affected by cannabis use and could pose a potential drug interaction. The chronic use of cannabis is associated with health issues, but the therapeutic potential is multifold since there is a regulatory role of ECS in many pathologies.

CONCLUSION

Current shortcomings in understanding the benefits of cannabis or hemp products are limited due to pharmacological and clinical effects not being predictable, while marketed products vary greatly in phytocompounds warrant further empirical investigation. Given the healthcare challenges to manage acute and chronic pain, this review highlights both cannabis and CBD-hemp extracts to help identify the therapeutic application for patient populations suffering from anxiety, inflammation, and dental pain.

摘要

简介

在过去的二十年中,我们对大麻的治疗用途和药用特性的理解发生了巨大变化。这种变化伴随着大麻在不同社区和不同年龄段人群中的广泛使用,尤其是在美国。随着这种增长,我们应该考虑大麻-大麻素对公众健康的潜在影响,以及它们如何改变治疗效果。

材料和方法

本研究调查了大麻的娱乐和治疗用途,并对相关索引文献进行了回顾。关注的问题评估了“大麻或大麻素产品如何影响健康参数,它们在牙科中是否具有潜在的治疗价值,以及它们如何与常规药物(药物)相互作用”。没有时间限制地搜索了索引数据库(PubMed/Medline、EMBASE),但语言仅限于英语。

结果

该综述强调了大麻使用的牙科问题,需要了解内源性大麻素系统(ECS)、大麻素受体系统、其内源性配体、药理学、代谢、当前口腔健康和医学困境,以确定使用大麻-大麻素产品的有害或有益影响。纯大麻二酚(CBD)的药理作用已得到广泛研究,而大麻提取物的差异可能很大,缺乏经验研究。几种代谢途径受到大麻使用的影响,可能存在潜在的药物相互作用。慢性使用大麻与健康问题有关,但治疗潜力是多方面的,因为 ECS 在许多病理中具有调节作用。

结论

由于大麻或大麻素产品的益处的理解受到限制,目前的缺点是药理学和临床效果不可预测,而市场上的产品在植物化合物方面差异很大,需要进一步的经验研究。鉴于管理急性和慢性疼痛的医疗保健挑战,本综述强调了大麻和 CBD-大麻素提取物,以帮助确定患有焦虑、炎症和牙痛的患者群体的治疗应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f94/9209799/af0d9a2fe50f/CRE2-8-613-g003.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验